Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Acacia Diversified Holdings, Inc. operates within the healthcare sector, focusing on the development and distribution of specialty and generic drugs. The company has faced significant operational challenges, reflected in its negative margins and low liquidity, which may hinder its competitive position against larger, more established pharmaceutical firms.
Acacia generates revenue primarily through the sale of generic and specialty pharmaceuticals, leveraging cost advantages in production. However, its low gross margin of 4.9% indicates significant pricing pressure and operational inefficiencies, limiting its pricing power.
Regulatory approvals for new drug formulations
Changes in healthcare policy affecting drug pricing
Competitive pricing strategies from larger pharmaceutical companies
Market demand shifts for generic vs. specialty drugs
Regulatory changes impacting drug approval processes
Technological disruption in drug manufacturing
Pricing pressure from larger competitors with more robust supply chains
Potential market entry by new generic drug manufacturers
Negative operating margins leading to liquidity issues
High reliance on short-term financing due to low current ratio
moderate - The healthcare sector is somewhat insulated from economic downturns, but drug demand can be influenced by consumer spending patterns.
High interest rates could increase financing costs for Acacia, impacting its ability to invest in R&D and operational improvements, which are critical for growth.
minimal - The company has a negative debt/equity ratio, indicating it is not reliant on external financing.
value - Investors may be attracted to the potential turnaround opportunities given the current low valuation metrics.
high - The stock has shown significant volatility, evidenced by a 50% decline over the past year.
